UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolated Brain Tuberculoma in Immunocompetent Patient With No Recent Travel History: Unusual Presentation for a Rare Disease Mimicking Primary Central Nervous System Tumor

Archives of pathology & laboratory medicine (1976), 2024-09, Vol.148 (9), p.E318-E319

2024

Volltextzugriff (PDF)

Synchronous B-Cell Acute Lymphoblastic Leukemia and Serous Ovarian Carcinoma: A Case Report

Case reports in oncology, 2021-11, Vol.14 (3), p.1621-1626

2021

Volltextzugriff (PDF)

Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach

Human Pathology Reports, 2021-11, Vol.26, p.300574, Article 300574

2021

Volltextzugriff (PDF)

An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma

Case reports in hematology, 2021-07, Vol.2021, p.1-5

2021

Volltextzugriff (PDF)

801 Overexpression of human TLR8 induces bone marrow dysfunction and severe anemia in lupus- prone mice

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A67-A69

2024

Volltextzugriff (PDF)

Vascular lesions of the breast: Essential pathologic features and diagnostic pitfalls

Human Pathology Reports, 2021-11, Vol.26, p.300570, Article 300570

2021

Volltextzugriff (PDF)

The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX ® Testing

Cancers, 2023-01, Vol.15 (3), p.903

2023

Volltextzugriff (PDF)

HER2-Low Breast Cancers: New Opportunities and Challenges

American journal of clinical pathology, 2022-03, Vol.157 (3), p.328-336

2022

Volltextzugriff (PDF)

HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles

Modern pathology, 2022-08, Vol.35 (8), p.1075-1082

2022

Volltextzugriff (PDF)

Mammary Adenomyoepithelioma in a 15-Year-Old Girl With Peutz-Jeghers Syndrome

Archives of pathology & laboratory medicine (1976), 2024-09, Vol.148 (9), p.E260-E260

2024

Volltextzugriff (PDF)

Primary Esophageal Melanoma with Aberrant CD56 Expression: A Potential Diagnostic Pitfall

Case reports in pathology, 2017-01, Vol.2017 (2017), p.1-4

2017

Volltextzugriff (PDF)

Abstract P4-05-09: Clinicopathologic characteristics and molecular profiling of HER2-low breast cancer: A single academic institution experience

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-05-09

2022

Volltextzugriff (PDF)

Abstract P4-06-03: Clinical-risk assessment of ER positive, Her2 negative breast cancer patients: Correlation between the average modified magee score and mammaprint

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-06-03

2022

Volltextzugriff (PDF)

HER2-Low Breast Cancers

American journal of clinical pathology, 2022-03, Vol.157 (3), p.328-336

2022

Volltextzugriff (PDF)

Clinical Utilization of Next-Generation Sequencing-Based Clonality Assays for Immunoglobulin Heavy Chain in Evaluating Suspected B-Cell Proliferation

American journal of clinical pathology, 2019-09, Vol.152 (Supplement_1), p.S134-S135

2019

Volltextzugriff (PDF)

HER2-low breast cancers: Current insights and future directions

Seminars in diagnostic pathology, 2022-09, Vol.39 (5), p.305-312

2022

Volltextzugriff (PDF)

Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-09-19

2022

Volltextzugriff (PDF)

Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low–Expressing Breast Cancer Cohort

American journal of clinical pathology, 2023-05, Vol.159 (5), p.484-491

2023

Volltextzugriff (PDF)

Fibrosis, Thrombosis, and Dacrocytosis: An Unusual Case of Male Systemic Lupus Erythematosus

The American journal of medicine, 2020-07, Vol.133 (7), p.810-813

2020

Volltextzugriff (PDF)

Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas

Human pathology, 2024-06, Vol.148, p.51-59

2024

Volltextzugriff (PDF)

HER2 in uterine serous carcinoma: Current state and clinical perspectives

American journal of clinical pathology, 2023-10, Vol.160 (4), p.341-351

2023

Volltextzugriff (PDF)

Abstract PS6-18: Are we missing something? Ki-67 evaluation is important in African American women with an oncotype DX score< 26: A multi-institutional study

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-18-PS6-18

2021

Volltextzugriff (PDF)

Abstract PS6-24: Are we missing something? Increased recurrence rates in patients with an oncotype DX score < 26 and a modified magee score > 18: A multi-institutional study

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-24-PS6-24

2021

Volltextzugriff (PDF)

ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor

Modern pathology, 2016-06, Vol.29 (6), p.591-598

2016

Volltextzugriff (PDF)

Placental Chorionic Cyst Fluid Has Prothrombotic Properties and Differs From Amniotic Fluid

Pediatric and developmental pathology, 2019-07, Vol.22 (4), p.304-314

2019

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(26)
Berichte
(3)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Isolated Brain Tuberculoma in Immunocompetent Patient With No Recent Travel History: Unusual Presentation for a Rare Disease Mimicking Primary Central Nervous System Tumor

Synchronous B-Cell Acute Lymphoblastic Leukemia and Serous Ovarian Carcinoma: A Case Report

Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach

An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma

801 Overexpression of human TLR8 induces bone marrow dysfunction and severe anemia in lupus- prone mice

Vascular lesions of the breast: Essential pathologic features and diagnostic pitfalls

The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX ® Testing

HER2-Low Breast Cancers: New Opportunities and Challenges

HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles

Mammary Adenomyoepithelioma in a 15-Year-Old Girl With Peutz-Jeghers Syndrome

Primary Esophageal Melanoma with Aberrant CD56 Expression: A Potential Diagnostic Pitfall

Abstract P4-05-09: Clinicopathologic characteristics and molecular profiling of HER2-low breast cancer: A single academic institution experience

Abstract P4-06-03: Clinical-risk assessment of ER positive, Her2 negative breast cancer patients: Correlation between the average modified magee score and mammaprint

HER2-Low Breast Cancers

Clinical Utilization of Next-Generation Sequencing-Based Clonality Assays for Immunoglobulin Heavy Chain in Evaluating Suspected B-Cell Proliferation

HER2-low breast cancers: Current insights and future directions

Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications

Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low–Expressing Breast Cancer Cohort

Fibrosis, Thrombosis, and Dacrocytosis: An Unusual Case of Male Systemic Lupus Erythematosus

Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas

HER2 in uterine serous carcinoma: Current state and clinical perspectives

Abstract PS6-18: Are we missing something? Ki-67 evaluation is important in African American women with an oncotype DX score< 26: A multi-institutional study

Abstract PS6-24: Are we missing something? Increased recurrence rates in patients with an oncotype DX score < 26 and a modified magee score > 18: A multi-institutional study

ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor

Placental Chorionic Cyst Fluid Has Prothrombotic Properties and Differs From Amniotic Fluid

Suchergebnisse filtern